Selective Phosphodiesterase Type 4 Inhibitors Reduce the Prolonged Survival of Eosinophils Stimulated by Granulocyte-Macrophage Colony-Stimulating Factor.

DOI Web Site Web Site PubMed 1 Citations 43 References Open Access
  • Takeuchi Masayuki
    Second Department of Internal Medicine and Laboratory Medicine, Nagoya University School of Medicine
  • Tatsumi Yasuaki
    Department of Medical Technology, Nagoya University School of Health Sciences
  • Kitaichi Kiyoyuki
    Department of Medical Technology, Nagoya University School of Health Sciences
  • Baba Kenji
    Third Department of Medicine, Aichi Medical School, School of Medicine
  • Suzuki Ryujiro
    Second Department of Internal Medicine and Laboratory Medicine, Nagoya University School of Medicine
  • Shibata Eiji
    Department of Medical Technology, Nagoya University School of Health Sciences
  • Takagi Kenji
    Department of Medical Technology, Nagoya University School of Health Sciences
  • Miyamoto Ken-ichi
    Department of Hospital Pharmacy, Kanazawa University School of Medicine
  • Hasegawa Takaaki
    Department of Medical Technology, Nagoya University School of Health Sciences
  • Takagi Kenzo
    Department of Medical Technology, Nagoya University School of Health Sciences

Search this article

Description

It is well known that bronchial asthma is defined as chronic eosinophilic inflammation of the respiratory tract and that as one of the various types of inflammatory cells, eosinophils induce the airway inflammation of chronic asthma. Granulocyte-macrophage colony-stimulating factor (GM-CSF) has been shown to play an important role in the prolongation of the survival of eosinophils. We investigated the inhibitory effect of the selective phosphodiesterase (PDE) 4 inhibitors, 3,4-dipropyl-4,5,7,8-tetrahydro-3H-imidazo[1,2-i]purin-5-one (XT-611) and rolipram, and the nonselective PDE inhibitor theophylline, against GM-CSF-induced prolongation of the survival of eosinophils isolated from patients with bronchial asthma. Eosinophils (106 cells/ml) were incubated in the presence of GM-CSF together with or without theophylline, rolipram or XT-611 at 37 °C, and the viable cells were assessed up to 4 d using Trypan blue dye exclusion. The presence of theophylline (10−4 M), rolipram (10−4—10−5 M) or XT-611 (10−4—10−5 M) significantly reduced the GM-CSF (10 pg/ml)-induced prolongation of viability of eosinophils. These findings suggest that selective PDE 4 inhibitors, including XT-611, may effectively reduce the activities of inflammatory cells in the airway of bronchial asthma patients.

Journal

Citations (1)*help

See more

References(43)*help

See more

Keywords

Details 詳細情報について

Report a problem

Back to top